Reldesemtiv Uses, Dosage, Side Effects and more
Reldesemtiv is under investigation in clinical trial NCT03160898 (A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS)).
| Trade Name | Reldesemtiv |
| Generic | Reldesemtiv |
| Reldesemtiv Other Names | CK-2127107, Reldesemtiv |
| Type | |
| Formula | C19H18F2N6O |
| Weight | Average: 384.391 Monoisotopic: 384.15101555 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
